Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study
Bjorn Gudbjornsson, Sigurdur B. Thorsteinsson, Helgi Sigvaldason, Rannveig Einarsdottir, Magnus Johannsson, Helga Zoega, Matthias Halldorsson, Gudmundur ThorgeirssonVolume:
66
Language:
english
Pages:
7
DOI:
10.1007/s00228-010-0789-2
Date:
June, 2010
File:
PDF, 134 KB
english, 2010